1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. CVRX INC
CVRx Inc
XNAS: CVRX
Weak Stock
Download real time
5.99 0.25 (4.36%)
46.99% Fall from 52W High
1.1M
XNAS Volume
High volume today

XNAS 15 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for CVRx Inc

The latest disclosure was made by Kevin Hykes in CVRx Inc where a trade of 159,000 Common Stock done was reported to US exchanges on Feb. 27, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kevin Hykes Director, PRES & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 159,000 292,000 - 0 Common Stock
Kevin Hykes Director, PRES & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 238,000 238,000 - - Stock Option (right to buy)
Kevin Hykes Director, PRES & CEO Sale of securities on an exchange or to another person at price $ 7.90 per share. 27 Feb 2026 7,763 284,237 - 7.9 61,349 Common Stock
Brent Binkowski CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 23,000 23,000 - - Stock Option (right to buy)
Brent Binkowski CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 15,000 31,600 - 0 Common Stock
Jared Oasheim CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 91,000 91,000 - - Stock Option (right to buy)
Jared Oasheim CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 61,000 98,447 - 0 Common Stock
Jared Oasheim CHIEF FINANCIAL OFFICER Sale of securities on an exchange or to another person at price $ 7.90 per share. 27 Feb 2026 1,744 96,703 - 7.9 13,781 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 45,000 61,835 - 0 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 67,000 67,000 - - Stock Option (right to buy)
Paul Verrastro CHIEF MKTG & STRAT OFFICER Sale of securities on an exchange or to another person at price $ 7.90 per share. 27 Feb 2026 1,284 60,551 - 7.9 10,146 Common Stock
Robert Allen John Chief Revenue Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 52,000 52,000 - - Stock Option (right to buy)
Robert Allen John Chief Revenue Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 35,000 90,000 - 0 Common Stock
Robert Allen John Chief Revenue Officer Sale of securities on an exchange or to another person at price $ 7.90 per share. 27 Feb 2026 3,964 86,036 - 7.9 31,326 Common Stock
Philip B. Adamson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 62,000 62,000 - - Stock Option (right to buy)
Philip B. Adamson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2026 41,000 62,840 - 0 Common Stock
Philip B. Adamson Chief Medical Officer Sale of securities on an exchange or to another person at price $ 7.90 per share. 27 Feb 2026 1,262 61,578 - 7.9 9,973 Common Stock
Mudit K. Jain Director Purchase of securities on an exchange or from another person at price $ 6.36 per share. 20 Feb 2026 46,800 980,183 - 6.4 297,592 Common Stock
Mudit K. Jain Director Purchase of securities on an exchange or from another person at price $ 4.64 per share. 18 Feb 2026 600 5,650 - 4.6 2,785 Common Stock
Brent Binkowski CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2025 74,900 74,900 - - Stock Option (right to buy)
Brent Binkowski CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2025 16,600 16,600 - 0 Common Stock
Joseph P. Slattery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2025 19,554 19,554 - - Stock Option (right to buy)
Kevin J. Ballinger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2025 19,554 19,554 - - Stock Option (right to buy)
Mitchell C. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2025 19,554 19,554 - - Stock Option (right to buy)
Mudit K. Jain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2025 19,554 19,554 - - Stock Option (right to buy)
Kirk Nielsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2025 19,554 19,554 - - Stock Option (right to buy)
Martha Shadan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2025 19,554 19,554 - - Stock Option (right to buy)
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 5.45 per share. 15 May 2025 10,966 1,910,134 - 5.5 59,795 Common Stock
Kevin Hykes Director, PRES & CEO Purchase of securities on an exchange or from another person at price $ 4.84 per share. 12 May 2025 5,000 133,000 - 4.8 24,200 Common Stock
Mudit K. Jain Director Purchase of securities on an exchange or from another person at price $ 4.66 per share. 12 May 2025 1,500 4,900 - 4.7 6,986 Common Stock
Mudit K. Jain Director Purchase of securities on an exchange or from another person at price $ 5.26 per share. 12 May 2025 150 5,050 - 5.3 789 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 4.79 per share. 12 May 2025 25,200 1,736,555 - 4.8 120,670 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 5.29 per share. 12 May 2025 101,413 1,837,968 - 5.3 536,313 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 5.23 per share. 12 May 2025 61,200 1,899,168 - 5.2 320,364 Common Stock
Kevin Hykes Director, PRES & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 98,000 128,000 - 0 Common Stock
Kevin Hykes Director, PRES & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 148,000 148,000 - - Stock Option (right to buy)
Jared Oasheim CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 22,000 37,447 - 0 Common Stock
Jared Oasheim CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 33,000 33,000 - - Stock Option (right to buy)
Paul Verrastro CHIEF MKTG & STRAT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 24,000 24,000 - - Stock Option (right to buy)
Paul Verrastro CHIEF MKTG & STRAT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 16,000 16,835 - 0 Common Stock
Robert Allen John Chief Revenue Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 55,000 55,000 - 0 Common Stock
Robert Allen John Chief Revenue Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 38,000 38,000 - - Stock Option (right to buy)
Philip B. Adamson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 30,000 30,000 - - Stock Option (right to buy)
Philip B. Adamson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 20,000 20,000 - 0 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Nov 2024 2,500 73,306 - - Stock Option (right to buy)
Paul Verrastro CHIEF MKTG & STRAT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.14 per share. 19 Nov 2024 2,500 3,305 - 5.1 12,853 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Sale of securities on an exchange or to another person at price $ 13.58 per share. 19 Nov 2024 1,430 1,875 - 13.6 19,417 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Gift of securities by or to the insider at price $ 0.00 per share. 19 Nov 2024 1,040 835 - 0 Common Stock
Kevin J. Ballinger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Sep 2024 36,136 36,136 - - Stock Option (right to buy)
Mitchell C. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Sep 2024 36,136 36,136 - - Stock Option (right to buy)
Joseph P. Slattery Director Purchase of securities on an exchange or from another person at price $ 8.10 per share. 15 Aug 2024 3,000 30,645 - 8.1 24,300 Common Stock
Joseph P. Slattery Director Purchase of securities on an exchange or from another person at price $ 8.24 per share. 08 Aug 2024 3,000 27,645 - 8.2 24,716 Common Stock
Joseph P. Slattery Director Purchase of securities on an exchange or from another person at price $ 9.09 per share. 06 Aug 2024 2,500 24,645 - 9.1 22,725 Common Stock
Kevin Hykes Director, PRES & CEO Purchase of securities on an exchange or from another person at price $ 8.36 per share. 05 Aug 2024 30,000 30,000 - 8.4 250,767 Common Stock
Kevin Hykes Director, PRES & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2024 180,000 180,000 - - Stock Option (right to buy)
Robert Allen John Chief Revenue Officer 27 Jun 2024 122,192 122,192 - - Stock Option (right to buy)
Joseph P. Slattery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 20,961 20,961 - - Stock Option (right to buy)
Ali Behbahani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 20,961 20,961 - - Stock Option (right to buy)
Mudit K. Jain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 20,961 20,961 - - Stock Option (right to buy)
Kirk Nielsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 20,961 20,961 - - Stock Option (right to buy)
Martha Shadan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 20,961 20,961 - - Stock Option (right to buy)
Joseph P. Slattery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 27,250 27,250 - - Stock Option (right to buy)
Ali Behbahani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 27,250 27,250 - - Stock Option (right to buy)
Mudit K. Jain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 27,250 27,250 - - Stock Option (right to buy)
Kirk Nielsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 27,250 27,250 - - Stock Option (right to buy)
Martha Shadan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2024 27,250 27,250 - - Stock Option (right to buy)
Craig E. Palmer SVP, U.S. SALES 25 Mar 2024 379 0 - - Stock Option (right to buy)
Craig E. Palmer SVP, U.S. SALES 25 Mar 2024 151 0 - - Stock Option (right to buy)
Craig E. Palmer SVP, U.S. SALES 25 Mar 2024 404 0 - - Stock Option (right to buy)
Craig E. Palmer SVP, U.S. SALES 25 Mar 2024 379 674 - 0.2 90 Common Stock
Craig E. Palmer SVP, U.S. SALES 25 Mar 2024 151 1,229 - 0.2 36 Common Stock
Craig E. Palmer SVP, U.S. SALES 25 Mar 2024 404 1,078 - 0.2 96 Common Stock
Verrastro Paul CHIEF MKTG & STRAT OFFICER Gift of securities by or to the insider at price $ 0.00 per share. 23 Feb 2024 1,650 805 - 0 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 5,000 75,806 - - Stock Option (right to buy)
Paul Verrastro CHIEF MKTG & STRAT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.14 per share. 20 Feb 2024 5,000 5,000 - 5.1 25,705 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Sale of securities on an exchange or to another person at price $ 21.90 per share. 20 Feb 2024 2,545 2,455 - 21.9 55,748 Common Stock
Hykes Kevin Director, PRES & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2024 360,000 360,000 - - Stock Option (right to buy)
E. Palmer Craig SVP, U.S. SALES 02 Feb 2024 31,600 31,600 - - Stock Option (right to buy)
Verrastro Paul CHIEF MKTG & STRAT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2024 32,000 32,000 - - Stock Option (right to buy)
Oasheim Jared CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2024 55,500 55,500 - - Stock Option (right to buy)
Nadim Yared Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2024 22,050 22,050 - - Stock Option (right to buy)
Yared Nadim Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 29 Jan 2024 4,055 24,310 - 0.2 961 Common Stock
Nadim Yared Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 29 Jan 2024 1,945 26,255 - 0.2 461 Common Stock
Nadim Yared Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2024 1,945 29,092 - - Stock Option (right to buy)
Yared Nadim Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2024 4,055 0 - - Stock Option (right to buy)
Slattery Joseph P. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. 28 Dec 2023 174 22,049 - 1.2 206 Common Stock
Joseph Slattery P. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.96 per share. 28 Dec 2023 96 22,145 - 4.0 380 Common Stock
P. Joseph Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Dec 2023 1,456 0 - - Stock Option (right to buy)
Joseph Slattery P. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 28 Dec 2023 224 20,419 - 0.2 53 Common Stock
Joseph Slattery P. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Dec 2023 174 0 - - Stock Option (right to buy)
P. Joseph Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Dec 2023 224 0 - - Stock Option (right to buy)
P. Joseph Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 28 Dec 2023 1,456 21,875 - 0.2 345 Common Stock
Joseph Slattery P. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Dec 2023 96 7,590 - - Stock Option (right to buy)
Ali Behbahani Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 14 Dec 2023 316 316 - 0.2 75 Common Stock
Ali Behbahani Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2023 316 0 - - Stock Option (right to buy)
Paul Verrastro CHIEF MKTG & STRAT OFFICER Sale of securities on an exchange or to another person at price $ 18.55 per share. 03 Aug 2023 628 0 - 18.6 11,652 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Sale of securities on an exchange or to another person at price $ 17.49 per share. 31 Jul 2023 1,122 2,628 - 17.5 19,629 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2023 3,750 80,806 - - Stock Option (right to buy)
Paul Verrastro CHIEF MKTG & STRAT OFFICER Gift of securities by or to the insider at price $ 0.00 per share. 31 Jul 2023 2,000 628 - 0 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.14 per share. 31 Jul 2023 3,750 3,750 - 5.1 19,279 Common Stock
Joseph P. Slattery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2023 12,012 12,012 - - Stock Option (right to buy)
Kevin Hykes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2023 12,012 12,012 - - Stock Option (right to buy)
Ali Behbahani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2023 12,012 12,012 - - Stock Option (right to buy)
Mudit K. Jain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2023 12,012 12,012 - - Stock Option (right to buy)
Kirk Nielsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2023 12,012 12,012 - - Stock Option (right to buy)
Martha Shadan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2023 12,012 12,012 - - Stock Option (right to buy)
Craig E. Palmer SVP, U.S. SALES 16 May 2023 295 295 - 0.2 70 Common Stock
Craig E. Palmer SVP, U.S. SALES 16 May 2023 295 0 - - Stock Option (right to buy)
Nadim Yared Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2023 200,000 200,000 - - Stock Option (right to buy)
Jared Oasheim CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2023 70,000 70,000 - - Stock Option (right to buy)
Liz Galle VP OF GLOBAL CLINICAL RESEARCH Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2023 26,000 26,000 - - Stock Option (right to buy)
Paul Verrastro CHIEF MKTG & STRAT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2023 45,000 45,000 - - Stock Option (right to buy)
Craig E. Palmer SVP, U.S. SALES 18 Jan 2023 40,000 40,000 - - Stock Option (right to buy)
Nadim Yared Director, CHIEF EXECUTIVE OFFICER Gift of securities by or to the insider at price $ 0.00 per share. 11 Jan 2023 7,080 20,255 - 0 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Nov 2022 9,000 84,556 - - Stock Option (right to buy)
Paul Verrastro CHIEF MKTG & STRAT OFFICER Gift of securities by or to the insider at price $ 0.00 per share. 28 Nov 2022 4,400 0 - 0 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Sale of securities on an exchange or to another person at price $ 12.52 per share. 28 Nov 2022 600 4,400 - 12.5 7,513 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Sale of securities on an exchange or to another person at price $ 11.85 per share. 28 Nov 2022 4,000 5,000 - 11.9 47,418 Common Stock
Paul Verrastro CHIEF MKTG & STRAT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.14 per share. 28 Nov 2022 9,000 9,000 - 5.1 46,269 Common Stock
Nadim Yared Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 60,000 60,000 - - Stock Option (right to buy)
Jared Oasheim CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 20,000 20,000 - - Stock Option (right to buy)
Dean Bruhn-Ding VP OF REG. AFFAIRS AND QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 6,000 6,000 - - Stock Option (right to buy)
Liz Galle VP OF GLOBAL CLINICAL RESEARCH Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 8,000 8,000 - - Stock Option (right to buy)
Paul Verrastro CHIEF MKTG & STRAT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 20,000 20,000 - - Stock Option (right to buy)
Craig E. Palmer SVP, U.S. SALES 02 Aug 2022 10,000 10,000 - - Stock Option (right to buy)
John M. Nehra Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 26,985 26,985 - - Stock Option (right to buy)
Joseph P. Slattery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 26,985 26,985 - - Stock Option (right to buy)
Ali Behbahani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 26,985 26,985 - - Stock Option (right to buy)
Mudit K. Jain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 26,985 26,985 - - Stock Option (right to buy)
Kirk Nielsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 26,985 26,985 - - Stock Option (right to buy)
Martha Shadan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 26,985 26,985 - - Stock Option (right to buy)
Jared Oasheim CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 02 Jun 2022 1,264 1,264 - 0.2 300 Common Stock
Jared Oasheim CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2022 2,633 527 - - Stock Option (right to buy)
Jared Oasheim CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2022 3,160 0 - - Stock Option (right to buy)
Jared Oasheim CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2022 2,528 0 - - Stock Option (right to buy)
Jared Oasheim CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2022 1,264 0 - - Stock Option (right to buy)
Jared Oasheim CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 02 Jun 2022 2,633 9,585 - 0.2 624 Common Stock
Jared Oasheim CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 02 Jun 2022 3,160 6,952 - 0.2 749 Common Stock
Jared Oasheim CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 02 Jun 2022 2,528 3,792 - 0.2 599 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 5.05 per share. 24 May 2022 8,070 1,711,355 - 5.0 40,752 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 5.04 per share. 19 May 2022 4,432 1,703,285 - 5.0 22,336 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 5.04 per share. 19 May 2022 13,387 1,698,853 - 5.0 67,409 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 5.04 per share. 19 May 2022 10,976 1,685,466 - 5.0 55,297 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 5.99 per share. 03 May 2022 25,503 1,670,498 - 6.0 152,760 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 6.00 per share. 03 May 2022 3,992 1,674,490 - 6.0 23,936 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 6.00 per share. 03 May 2022 32,809 1,644,995 - 6.0 196,762 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 5.97 per share. 28 Apr 2022 41,988 1,612,186 - 6.0 250,673 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 5.97 per share. 28 Apr 2022 100 1,570,198 - 6.0 597 Common Stock
Nadim Yared Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 25 Apr 2022 6,059 27,335 - 0.2 1,436 Common Stock
Nadim Yared Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Apr 2022 6,059 4,055 - - Stock Option (right to buy)
John Brintnall CHIEF STRATEGY OFFICER AND SEC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 22 Apr 2022 1,264 21,901 - 0.2 300 Common Stock
John Brintnall CHIEF STRATEGY OFFICER AND SEC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 22 Apr 2022 3,792 20,637 - 0.2 899 Common Stock
John Brintnall CHIEF STRATEGY OFFICER AND SEC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 22 Apr 2022 2,221 16,845 - 0.2 526 Common Stock
John Brintnall CHIEF STRATEGY OFFICER AND SEC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 22 Apr 2022 1,590 12,040 - 0.2 377 Common Stock
John Brintnall CHIEF STRATEGY OFFICER AND SEC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 22 Apr 2022 2,584 14,624 - 0.2 612 Common Stock
John Brintnall CHIEF STRATEGY OFFICER AND SEC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Apr 2022 1,264 0 - - Stock Option (right to buy)
John Brintnall CHIEF STRATEGY OFFICER AND SEC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Apr 2022 3,792 0 - - Stock Option (right to buy)
John Brintnall CHIEF STRATEGY OFFICER AND SEC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Apr 2022 2,221 0 - - Stock Option (right to buy)
John Brintnall CHIEF STRATEGY OFFICER AND SEC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Apr 2022 2,584 702 - - Stock Option (right to buy)
John Brintnall CHIEF STRATEGY OFFICER AND SEC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Apr 2022 1,590 685 - - Stock Option (right to buy)
Mudit K. Jain Director Purchase of securities on an exchange or from another person at price $ 9.03 per share. 28 Feb 2022 600 3,400 - 9.0 5,420 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 8.24 per share. 24 Feb 2022 3,400 1,570,098 - 8.2 28,010 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 8.04 per share. 18 Feb 2022 38,200 1,566,698 - 8.0 307,143 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 7.92 per share. 18 Feb 2022 26,659 1,488,490 - 7.9 211,227 Common Stock
Kirk Nielsen Director Purchase of securities on an exchange or from another person at price $ 7.94 per share. 18 Feb 2022 40,008 1,528,498 - 7.9 317,660 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 2,275 0 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 780 20,428 - 0.2 185 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 12,383 32,811 - 0.2 2,935 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 2,862 35,673 - 0.2 678 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 1,264 36,937 - 0.2 300 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 1,264 38,201 - 0.2 300 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 2,528 40,729 - 0.2 599 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 1,169 41,898 - 0.2 277 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 821 42,719 - 0.2 195 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 378 43,097 - 0.2 90 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 1,590 44,687 - 0.2 377 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 2,528 47,215 - 0.2 599 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 2,275 49,490 - 0.2 539 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 08 Feb 2022 5,158 54,648 - 0.2 1,222 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 780 315 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 12,383 4,128 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 2,862 0 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 1,264 0 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 1,264 0 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 2,528 0 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 1,169 0 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 821 0 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 378 0 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 1,590 0 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 2,528 0 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2022 5,158 2,048 - - Stock Option (right to buy)
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 03 Feb 2022 1,266 21,276 - 0.2 300 Common Stock
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 03 Feb 2022 5,916 20,010 - 0.2 1,402 Common Stock
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 03 Feb 2022 3,792 14,094 - 0.2 899 Common Stock
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 03 Feb 2022 5,057 10,302 - 0.2 1,199 Common Stock
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 03 Feb 2022 2,659 5,245 - 0.2 630 Common Stock
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Feb 2022 1,266 11,375 - - Common Stock
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Feb 2022 5,916 0 - - Stock Option (right to buy)
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Feb 2022 3,792 0 - - Stock Option (right to buy)
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Feb 2022 5,057 0 - - Stock Option (right to buy)
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Feb 2022 2,659 0 - - Stock Option (right to buy)
Nadim Yared Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 18 Jan 2022 10,500 2,586 - 0 Common Stock
Nadim Yared Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2022 186,400 186,400 - - Stock Option (right to buy)
Jared Oasheim Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2022 56,200 56,200 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2022 23,600 23,600 - - Stock Option (right to buy)
Liz Galle VP of Global Clinical Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2022 25,900 25,900 - - Stock Option (right to buy)
Paul Verrastro Chief Marketing Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2022 41,200 41,200 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 13 Jan 2022 2,149 10,704 - 0.2 509 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 13 Jan 2022 316 14,937 - 0.2 75 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 13 Jan 2022 316 15,253 - 0.2 75 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 13 Jan 2022 2,528 17,781 - 0.2 599 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 13 Jan 2022 189 17,970 - 0.2 45 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 13 Jan 2022 189 18,159 - 0.2 45 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 13 Jan 2022 189 18,348 - 0.2 45 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 13 Jan 2022 189 18,537 - 0.2 45 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 13 Jan 2022 316 18,853 - 0.2 75 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 13 Jan 2022 758 19,611 - 0.2 180 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. 13 Jan 2022 584 20,195 - 1.2 693 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 2,149 224 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 3,917 1,456 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 316 0 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 2,528 0 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 316 0 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 584 174 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 758 0 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 316 0 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 189 0 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 189 0 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 189 0 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 13 Jan 2022 3,917 14,621 - 0.2 928 Common Stock
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 189 0 - - Stock Option (right to buy)
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 28 Dec 2021 2,080 13,086 - 0.2 493 Common Stock
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Dec 2021 2,080 2,659 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2021 3,000 2,373 - - Stock Option (right to buy)
Joseph P. Slattery Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 30 Nov 2021 3,000 8,555 - 0.2 720 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 24 Nov 2021 14,000 19,648 - 0.2 3,360 Common Stock
Dean Bruhn-Ding VP of Reg. Affairs and QA Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Nov 2021 14,000 1,095 - - Stock Option (right to buy)
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Nov 2021 11,006 4,739 - - Stock Option (right to buy)
Nadim Yared Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. 22 Nov 2021 11,006 11,006 - 0.2 2,641 Common Stock
Mudit K. Jain Director Purchase of securities on an exchange or from another person at price $ 13.69 per share. 18 Nov 2021 300 2,800 - 13.7 4,106 Common Stock
Mudit K. Jain Director Purchase of securities on an exchange or from another person at price $ 14.63 per share. 18 Nov 2021 875 2,500 - 14.6 12,804 Common Stock
Mudit K. Jain Director Purchase of securities on an exchange or from another person at price $ 19.72 per share. 12 Aug 2021 625 1,625 - 19.7 12,328 Common Stock
Martha Shadan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jul 2021 24,885 24,885 - - Stock Option (right to buy)
Martha Shadan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jul 2021 9,988 9,988 - - Stock Option (right to buy)
Joseph P. Slattery Director Grant, award, or other acquisition of securities at price $ 18.00 per share. 02 Jul 2021 5,555 5,555 - 18 99,990 Common Stock
Geoff Pardo Director 02 Jul 2021 24,583,397 0 - - Series G Preferred Stock
Geoff Pardo Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 02 Jul 2021 275,000 1,829,022 - 18 4,950,000 Common Stock
Geoff Pardo Director 02 Jul 2021 1,554,022 1,554,022 - - Common Stock
Kirk Nielsen Director 02 Jul 2021 1,461,831 1,461,831 - - Common Stock
Kirk Nielsen Director 02 Jul 2021 23,125,000 0 - - Series G Preferred Stock
John Brintnall Chief Strategy Officer and Sec 02 Jul 2021 89,518 0 - - Series G-2 Preferred Stock
John Brintnall Chief Strategy Officer and Sec 02 Jul 2021 88,653 0 - - Series F-2 Preferred Stock
John Brintnall Chief Strategy Officer and Sec 02 Jul 2021 5,658 7,900 - - Common Stock
John Brintnall Chief Strategy Officer and Sec 02 Jul 2021 2,242 2,242 - - Common Stock
Mudit K. Jain Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 01 Jul 2021 222,222 933,383 - 18 3,999,996 Common Stock
Mudit K. Jain Director 01 Jul 2021 11,250,000 0 - - Series G Preferred Stock
Mudit K. Jain Director Purchase of securities on an exchange or from another person at price $ 25.10 per share. 01 Jul 2021 1,000 1,000 - 25.1 25,100 Common Stock
Mudit K. Jain Director 01 Jul 2021 711,161 711,161 - - Common Stock
John M. Nehra Director Purchase of securities on an exchange or from another person at price $ 25.80 per share. 30 Jun 2021 50 100 - 25.8 1,290 Common Stock
John M. Nehra Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 30 Jun 2021 27,777 28,266 - 18 499,986 Common Stock
John M. Nehra Director Purchase of securities on an exchange or from another person at price $ 27.42 per share. 30 Jun 2021 50 50 - 27.4 1,371 Common Stock
John M. Nehra Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 9,100 9,100 - - Stock Option (right to buy)
John M. Nehra Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 10,382 10,382 - - Stock Option (right to buy)
Joseph P. Slattery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 10,382 10,382 - - Stock Option (right to buy)
Joseph P. Slattery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 9,100 9,100 - - Stock Option (right to buy)
Nadim Yared Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 97,800 97,800 - - Stock Option (right to buy)
Ali Behbahani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 10,382 10,382 - - Stock Option (right to buy)
Mudit K. Jain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 10,382 10,382 - - Stock Option (right to buy)
Geoff Pardo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 10,382 10,382 - - Stock Option (right to buy)
Kirk Nielsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 10,382 10,382 - - Stock Option (right to buy)
Jared Oasheim Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 36,700 36,700 - - Stock Option (right to buy)
John Brintnall Chief Strategy Officer and Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 18,300 18,300 - - Stock Option (right to buy)
Dean Bruhn-Ding VP of Reg. Affairs and QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 19,000 19,000 - - Stock Option (right to buy)
Liz Galle VP of Global Clinical Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 19,700 19,700 - - Stock Option (right to buy)
Paul Verrastro Chief Marketing Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2021 19,000 19,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters